A systematic review on the quality, validity and usefulness of current cost-effectiveness studies for treatments of neovascular age-related macular degeneration
Author:
Affiliation:
1. Maastricht University Medical Center; University Eye Clinic Maastricht; Maastricht The Netherlands
Funder
ZonMw
Publisher
Wiley
Subject
Ophthalmology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/aos.13824/fullpdf
Reference74 articles.
1. Health economic evaluations: how to find them;Alton;Int J Technol Assess Health Care,2006
2. Cost-effectiveness analysis of ranibizumab versus verteporfin photodynamic therapy, pegaptanib sodium, and best supportive care for the treatment of age-related macular degeneration in Greece;Athanasakis;Clin Ther,2012
3. Determinants of health related quality of life and health state utility in patients with age related macular degeneration: the association of contrast sensitivity and visual acuity;Bansback;Qual Life Res,2007a
4. Using contrast sensitivity to estimate the cost-effectiveness of verteporfin in patients with predominantly classic age-related macular degeneration (Provisional abstract);Bansback;Eye,2007b
5. Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol;Berg;Ophthalmology,2015
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Guest editor foreword: real-world evidence and medical affairs;Current Medical Research and Opinion;2023-12-02
2. Cost impact of different treatment regimens of brolucizumab in neovascular age-related macular degeneration: A budget impact analysis;Journal of Managed Care & Specialty Pharmacy;2022-12
3. Drop in well-being of ARMD patients under treatment with anti-VEGF injections during the COVID-19 pandemic;International Ophthalmology;2022-04-01
4. Switching to aflibercept versus continuing bevacizumab for treatment‐resistant neovascular age‐related macular degeneration: a one‐year comparative observational study;Acta Ophthalmologica;2021-02-26
5. Influence of unilateral intravitreal bevacizumab injection on the incidence of symptomatic choroidal neovascularization in the fellow eye in patients with neovascular age‑related macular degeneration (Review);Experimental and Therapeutic Medicine;2020-10-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3